These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30451546)

  • 1. Biomarkers for bipolar disorder: current status and challenges ahead.
    Teixeira AL; Colpo GD; Fries GR; Bauer IE; Selvaraj S
    Expert Rev Neurother; 2019 Jan; 19(1):67-81. PubMed ID: 30451546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Update on bipolar disorder biomarker candidates.
    Teixeira AL; Salem H; Frey BN; Barbosa IG; Machado-Vieira R
    Expert Rev Mol Diagn; 2016 Nov; 16(11):1209-1220. PubMed ID: 27737600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel biomarkers for bipolar disorder.
    Teixeira AL; Barbosa IG; Machado-Vieira R; Rizzo LB; Wieck A; Bauer ME
    Expert Opin Med Diagn; 2013 Mar; 7(2):147-59. PubMed ID: 23530885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential biomarkers for bipolar disorder: Where do we stand?
    Sagar R; Pattanayak RD
    Indian J Med Res; 2017 Jan; 145(1):7-16. PubMed ID: 28574009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective and biological markers in bipolar spectrum presentations.
    Chakrabarty T; Yatham LN
    Expert Rev Neurother; 2019 Mar; 19(3):195-209. PubMed ID: 30761925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalized management of bipolar disorder.
    Alda M; Manchia M
    Neurosci Lett; 2018 Mar; 669():3-9. PubMed ID: 29208408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biological hypotheses and biomarkers of bipolar disorder.
    Sigitova E; Fišar Z; Hroudová J; Cikánková T; Raboch J
    Psychiatry Clin Neurosci; 2017 Feb; 71(2):77-103. PubMed ID: 27800654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current state of biomarkers in bipolar disorder.
    Scola G; Andreazza AC
    Curr Psychiatry Rep; 2014 Dec; 16(12):514. PubMed ID: 25308386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomarkers and staging of bipolar disorder: a systematic review.
    Roda Â; Chendo I; Kunz M
    Trends Psychiatry Psychother; 2015; 37(1):3-11. PubMed ID: 25860561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bipolar disorder staging and the impact it has on its management: an update.
    Dell'Osso B; Cremaschi L; Macellaro M; Cafaro R; Girone N
    Expert Rev Neurother; 2024 Jun; 24(6):565-574. PubMed ID: 38753491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteomic approaches to identify blood-based biomarkers for depression and bipolar disorders.
    Preece RL; Han SYS; Bahn S
    Expert Rev Proteomics; 2018 Apr; 15(4):325-340. PubMed ID: 29466886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric bipolar disorder: a review of the past 10 years.
    Pavuluri MN; Birmaher B; Naylor MW
    J Am Acad Child Adolesc Psychiatry; 2005 Sep; 44(9):846-71. PubMed ID: 16113615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward stratified treatments for bipolar disorders.
    Hasler G; Wolf A
    Eur Neuropsychopharmacol; 2015 Mar; 25(3):283-94. PubMed ID: 25595029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological aspects and candidate biomarkers for psychotic bipolar disorder: A systematic review.
    Buoli M; Caldiroli A; Cumerlato Melter C; Serati M; de Nijs J; Altamura AC
    Psychiatry Clin Neurosci; 2016 Jun; 70(6):227-44. PubMed ID: 26969211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Machine learning approaches for prediction of bipolar disorder based on biological, clinical and neuropsychological markers: A systematic review and meta-analysis.
    Colombo F; Calesella F; Mazza MG; Melloni EMT; Morelli MJ; Scotti GM; Benedetti F; Bollettini I; Vai B
    Neurosci Biobehav Rev; 2022 Apr; 135():104552. PubMed ID: 35120970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peripheral markers of oxidative stress and antioxidative defense in euthymia of bipolar disorder--Gender and obesity effects.
    Bengesser SA; Lackner N; Birner A; Fellendorf FT; Platzer M; Mitteregger A; Unterweger R; Reininghaus B; Mangge H; Wallner-Liebmann SJ; Zelzer S; Fuchs D; McIntyre RS; Kapfhammer HP; Reininghaus EZ
    J Affect Disord; 2015 Feb; 172():367-74. PubMed ID: 25451439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of machine learning techniques in the study of bipolar disorder: A systematic review.
    Librenza-Garcia D; Kotzian BJ; Yang J; Mwangi B; Cao B; Pereira Lima LN; Bermudez MB; Boeira MV; Kapczinski F; Passos IC
    Neurosci Biobehav Rev; 2017 Sep; 80():538-554. PubMed ID: 28728937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An overview of metabolomic and proteomic profiling in bipolar disorder and its clinical value.
    Ribeiro HC; Zandonadi FDS; Sussulini A
    Expert Rev Proteomics; 2023; 20(11):267-280. PubMed ID: 37830362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digital Phenotyping in Bipolar Disorder: Which Integration with Clinical Endophenotypes and Biomarkers?
    Orsolini L; Fiorani M; Volpe U
    Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33081393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lithium, Stress, and Resilience in Bipolar Disorder: Deciphering this key homeostatic synaptic plasticity regulator.
    Machado-Vieira R
    J Affect Disord; 2018 Jun; 233():92-99. PubMed ID: 29310970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.